CN111298092B - Traditional Chinese medicine for treating secondary dysmenorrhea - Google Patents
Traditional Chinese medicine for treating secondary dysmenorrhea Download PDFInfo
- Publication number
- CN111298092B CN111298092B CN202010286633.9A CN202010286633A CN111298092B CN 111298092 B CN111298092 B CN 111298092B CN 202010286633 A CN202010286633 A CN 202010286633A CN 111298092 B CN111298092 B CN 111298092B
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- portions
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 38
- 206010013935 Dysmenorrhoea Diseases 0.000 title claims abstract description 30
- 244000236658 Paeonia lactiflora Species 0.000 claims abstract description 22
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims abstract description 19
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 16
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 16
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 14
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 13
- 235000011477 liquorice Nutrition 0.000 claims abstract description 13
- 241000218671 Ephedra Species 0.000 claims abstract description 12
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 12
- 235000008397 ginger Nutrition 0.000 claims abstract description 12
- 244000183685 Citrus aurantium Species 0.000 claims abstract description 11
- 235000007716 Citrus aurantium Nutrition 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 244000273928 Zingiber officinale Species 0.000 claims abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 241000202726 Bupleurum Species 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 210000003056 antler Anatomy 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 17
- 210000004185 liver Anatomy 0.000 abstract description 17
- 208000024891 symptom Diseases 0.000 abstract description 9
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 238000010792 warming Methods 0.000 abstract description 5
- 239000008280 blood Substances 0.000 description 33
- 210000004369 blood Anatomy 0.000 description 32
- 230000027758 ovulation cycle Effects 0.000 description 13
- 208000005171 Dysmenorrhea Diseases 0.000 description 10
- 230000005906 menstruation Effects 0.000 description 10
- 235000006484 Paeonia officinalis Nutrition 0.000 description 9
- 241000382455 Angelica sinensis Species 0.000 description 8
- 241000234314 Zingiber Species 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 241000736199 Paeonia Species 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 206010063659 Aversion Diseases 0.000 description 3
- 244000236521 Bupleurum rotundifolium Species 0.000 description 3
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 208000027697 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 208000005641 Adenomyosis Diseases 0.000 description 2
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 description 2
- 208000028685 Asherman syndrome Diseases 0.000 description 2
- 241000132012 Atractylodes Species 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 201000009273 Endometriosis Diseases 0.000 description 2
- 241000112528 Ligusticum striatum Species 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 241001106477 Paeoniaceae Species 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- 244000197580 Poria cocos Species 0.000 description 2
- 235000008599 Poria cocos Nutrition 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 201000001389 adhesions of uterus Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 201000009274 endometriosis of uterus Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010011953 Decreased activity Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- BJJXHLWLUDYTGC-ANULTFPQSA-N Gestrinone Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](CC)([C@](CC3)(O)C#C)C=C3)C3=C21 BJJXHLWLUDYTGC-ANULTFPQSA-N 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000019229 Spleen disease Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229960000766 danazol Drugs 0.000 description 1
- POZRVZJJTULAOH-LHZXLZLDSA-N danazol Chemical compound C1[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=CC2=C1C=NO2 POZRVZJJTULAOH-LHZXLZLDSA-N 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 229960004761 gestrinone Drugs 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 229960003248 mifepristone Drugs 0.000 description 1
- VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 201000001218 polyp of corpus uteri Diseases 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 230000001148 spastic effect Effects 0.000 description 1
- 208000027140 splenic disease Diseases 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 206010046811 uterine polyp Diseases 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating secondary dysmenorrhea, which is prepared from the following raw materials in parts by weight: 80-180 parts of white peony root, 30-90 parts of radix bupleuri, 30-90 parts of angelica, 30-90 parts of cornu cervi degelatinatum, 5-50 parts of ephedra, 5-50 parts of baked ginger, 30-90 parts of immature bitter orange and 20-60 parts of liquorice. The invention has the functions of soothing liver, regulating qi, warming yang and relieving pain, is used for secondary dysmenorrhea and can relieve clinical symptoms. The invention has the advantages of definite curative effect, high safety, small dosage, high compliance and the like.
Description
Technical Field
The invention belongs to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine for treating secondary dysmenorrhea.
Technical Field
Dysmenorrhea is one of the most common gynecological diseases, and refers to the symptoms of distending pain or cramp of lower abdomen, spasm or distending pain before and after menstruation or during menstruation, which can be radiated to the lumbosacral part, the inner side of thigh and around anus, and may be accompanied by pale complexion, nausea, vomiting, aversion to cold, frequent stool, and collapse during severe pain. The dysmenorrhea can directly influence normal work and life, and has a close relationship with infertility, and clinical observation shows that about more than half of patients with infertility are accompanied by dysmenorrhea with different degrees, so that the active treatment of the disease is very important for the patients.
Dysmenorrhea is classified into primary dysmenorrhea and secondary dysmenorrhea, and the primary dysmenorrhea is also called functional dysmenorrhea, and the patient who has no obvious abnormality of pelvic organs cannot be found. While secondary dysmenorrhea refers to those with obvious pathological changes of the genital organs, such as endometriosis, pelvic inflammation, adenomyosis, intrauterine adhesion, tumor, etc. Currently, secondary dysmenorrhea is mainly treated by medicines, a prostaglandin synthetase inhibitor such as ibuprofen and indometacin is usually adopted by western medicine to relieve uterine spastic contraction so as to relieve pain, or a progestogen receptor antagonist mifepristone is used to cause amenorrhea, and other medicines also comprise oral contraceptives and androgen derivatives such as gestrinone and danazol. Although these drugs have good analgesic effect, it is difficult to prevent the recurrence of dysmenorrhea, and hormones cause hypoactive sexual desire, menopause and other various systemic adverse reactions, and patient tolerance and compliance are poor.
The traditional Chinese medicine considers that the fundamental reason for the occurrence of dysmenorrhea is that qi and blood of viscera are unsmooth in circulation, and pain is caused by qi and blood obstruction or qi and blood deficiency of viscera. Therefore, the traditional Chinese medicine treats the dysmenorrheal according to syndrome differentiation from the aspect of regulating qi and blood circulation of viscera. The traditional Chinese medicine distinguishes and classifies the secondary dysmenorrhea into several types of qi stagnation and blood stasis, congealing cold and blood stasis, kidney deficiency and blood stasis and damp-heat stasis, and the treatment rules are different according to different types of symptoms, for example, qi stagnation and blood stasis mainly takes qi circulation and liver soothing, congealing cold and blood stasis mainly takes channel warming and cold dispelling.
In the ' jin Kui Yao L ü e ' a Dang Gui Shao powder is recorded in the Furen's article, which is composed of 6 kinds of Chinese herbs of liver-regulating and blood-nourishing angelica, peony and Ligusticum wallichii, and spleen-invigorating and dampness-removing poria cocos, white atractylodes rhizome and alisma orientale. The formula achieves the aims of regulating liver, nourishing blood, tonifying spleen and removing dampness through simultaneous treatment of blood and water and regulation of liver and spleen, so that the formula can be used for treating dysmenorrhea caused by liver and spleen disorder and qi depression, blood stagnation and damp obstruction, and has a special effect on soothing liver and regulating spleen. The invention is modified on the basis of the angelica and white peony powder, so as to obtain better curative effect on secondary dysmenorrhea.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine for treating secondary dysmenorrhea, which has better curative effect.
The above purpose is realized by the following technical scheme:
the applicant takes angelica sinensis and liquorice powder in 'jin Kui Yao L ü e' as a basic formula, and obtains a novel traditional Chinese medicine for treating secondary dysmenorrhea by disassembling and re-composing the formula with three traditional Chinese medicine classic formulas of a peony root and liquorice decoction, a yang harmonizing decoction and a Sini san on the basis of the dialectical treatment of the traditional Chinese medicine, wherein the traditional Chinese medicine is prepared from the following raw materials in parts by weight: 80-180 parts of white peony root, 30-90 parts of radix bupleuri, 30-90 parts of angelica, 30-90 parts of cornu cervi degelatinatum, 5-50 parts of ephedra, 5-50 parts of baked ginger, 30-90 parts of immature bitter orange and 20-60 parts of liquorice.
Preferably, the raw materials comprise the following components in parts by weight: 100 portions of white peony root, 50 to 70 portions of bupleurum, 50 to 70 portions of angelica, 50 to 70 portions of deglued antler powder, 10 to 30 portions of ephedra, 10 to 30 portions of baked ginger, 50 to 70 portions of immature bitter orange and 30 to 50 portions of liquorice.
Further preferably, the raw materials comprise the following components in parts by weight: 120 parts of white peony root, 60 parts of radix bupleuri, 60 parts of angelica, 60 parts of cornu cervi degelatinatum, 20 parts of ephedra, 20 parts of baked ginger, 60 parts of immature bitter orange and 40 parts of liquorice.
The applicant comprehensively adopts treatment principles of warming yang and promoting qi circulation, nourishing blood and liver, dispelling cold and relieving pain and the like according to the treatment principles of deficiency, cold accumulation and qi stagnation of women's diseases, lower abdomen aversion to cold or waist ridge leading, lower root qi street and acute pain of qi rushing, and the like, and concretely solves the following steps:
leaf Tianshi cloud of clinical evidence guideline medical record: the invention mainly uses white paeony root which can nourish blood, soften liver and relieve spasm and pain as a monarch and uses angelica and radix bupleuri as ministers. The angelica is sweet in taste, can help white peony root to nourish blood, can promote blood circulation, activate collaterals and relieve pain, and can strengthen the effect of relieving pain of white peony root, the pungent property is pungent and warm, the mild cold property of white peony root can be relieved when the pungent property is warm, the pungent property can be dispersed to the moderate acid property of white peony root, the cold and warm properties of the angelica and the white peony root are proper when the angelica and the white peony root are compatible, the astringency is good, and the effects of softening liver, nourishing blood and relieving pain are achieved together; radix bupleuri, radix bupleuri, radix and radix bupleuri, and radix Angelicae sinensis, and radix bupleuri, wherein the parts of liver-radix bupleuri, the parts of soothing liver-radix bupleuri, the parts of the essence of the radix bupleuri, the parts of the radix bupleuri, the parts of the radix bupleuri, the essence of the radix bupleuri, the radix, the essence of the radix bupleuri, the essence of the internal organs, the essence of the parts of the essence of the parts of the qi are harmonizing the qi of the qi are harmonizing, and the qi of the qi, and the part of the qi of the part of the less, and the part of the qi are harmonizing, harmonizing the less, and the ministeries, and the less yang, entering the point, and the less yang, and the part of the point.
Cornu cervi degelatinatum is a product with blood and meat emotion, has mild effect similar to that of cornu cervi pantotrichum, warms kidney and invigorates yang, tonifies governor vessel, and adds essence and blood; the ephedra herb is the lightest of the odors, can penetrate out of skin pores, and can also penetrate into phlegm and stop blood to achieve the effects of dispelling cold and removing stagnation; the baked ginger warms the channels to relieve pain, warms the spleen and harmonizes the stomach to stimulate the source of qi and blood generation; qing, wujutong (nu zhu bing bei) as the predicate: in the recipe, Zhi Shi Zhi has the actions of breaking qi and moving stagnancy, removing fullness and removing food retention, chai Hu soothes liver and regulates qi, and is used together to promote qi circulation to promote blood circulation and alleviate pain. The combination of the four herbs can promote blood circulation of the blood by Bai Shao and Dang Gui, and control the cold of chai Hu and Bai Shao, so they are combined as an adjuvant drug in the recipe.
Licorice root, radix Glycyrrhizae tonifies the spleen and qi, and coordinates the effects of the other drugs in the recipe.
Compared with the Chinese angelica and peony powder, one of the biggest characteristics of the Chinese angelica and peony powder is that the functions of soothing the liver and regulating qi are strengthened, but the functions of strengthening the spleen and promoting diuresis are weakened, and the Chinese angelica and peony powder emphasizes on regulating the etiology of dysmenorrhea, namely 'stagnation of qi'. The traditional Chinese medicine considers that the liver stores blood, regulates and releases qi, the liver releases qi and blood can regulate the balance of qi and blood, and the liver releases qi normally, so that qi and blood are harmonized. Therefore, the invention combines the bupleurum, the white paeony root, the immature bitter orange and the liquorice to comprehensively regulate the qi-blood balance of the human body, and harmonizes the liver and the spleen to ensure that the functions of liver storing blood and spleen generating blood run normally; the combination of the two herbs can make qi movement ascending and descending orderly, while the combination of chai Hu and Zhi Shi can make qi movement opening and closing degree proper.
Compared with the angelica sinensis and peony root powder, the invention has the other advantage that the functions of warming yang and dispelling cold are strengthened according to the cold accumulation characteristic of dysmenorrheal. Cold stagnation means that the circulation of qi, blood and body fluids of the human body is promoted by the warming of yang qi. When cold invades the body, the qi and blood in the meridians are obstructed by yang-qi, which can cause pain due to stagnation of qi and blood. The cornu cervi degelatinatum, the ephedra stem and the baked ginger can warm and dredge the pungent powder, act on the upper, middle and lower triple energizers of a human body, warm the qi and raise the blood, and the qi and blood can circulate unimpededly, so that the pain is relieved or eliminated.
The invention further provides a method for preparing the traditional Chinese medicine, which comprises the following steps:
1) extracting radix Paeoniae alba, bupleuri radix, and fructus Aurantii Immaturus with 50-80% ethanol under reflux for 0.5-2 hr for 1-3 times, mixing extractive solutions, and concentrating until no alcohol smell exists;
2) decocting radix Angelicae sinensis, Glycyrrhrizae radix, cornu Cervi Degelatinatum, herba Ephedrae, and rhizoma Zingiberis Preparata in water for 0.5-3 hr for 2-5 times, mixing extractive solutions, adding the concentrated medicinal liquid of step 1), and concentrating to obtain soft extract;
3) adding adjuvants into the soft extract, and making into clinical preparation.
Preferably, the medicament is an oral preparation, including granules, tablets, capsules, pills, powder, oral liquid, syrup and the like.
The invention has the beneficial effects that: the traditional Chinese medicine provided by the invention has better curative effect on secondary dysmenorrhea, and clinical tests prove that the effective rate of the traditional Chinese medicine is as high as 93.3%, which is obviously superior to that of the angelica and white peony powder, and the effective rate of the traditional Chinese medicine can still be kept at 71.4% after the medicine is stopped for the last time until the next menstrual cycle, which is extremely superior to that of the angelica and white peony powder, so that the traditional Chinese medicine also has better long-term curative effect. The invention also has the advantages of less adverse reaction, less dosage compared with the existing powder and pill, higher compliance and the like.
Detailed Description
The present invention will be described in detail below with reference to specific examples.
Example 1
120g of white peony root, 60g of Chinese thorowax root, 60g of Chinese angelica, 60g of cornu cervi degelatinatum, 20g of ephedra herb, 20g of baked ginger, 60g of immature bitter orange and 40g of liquorice
The preparation method comprises the following steps: 1) extracting radix Paeoniae alba, bupleuri radix, and fructus Aurantii Immaturus with 70% (by weight) ethanol under reflux for 2 times, each time for 1.5 hr, the ethanol used in each extraction is 8 times of the weight of the medicinal materials, mixing extractive solutions, and concentrating until there is no alcohol smell;
2) decocting radix Angelicae sinensis, Glycyrrhrizae radix, cornu Cervi Degelatinatum, herba Ephedrae, and rhizoma Zingiberis Preparata in water for 3 times, 2 hr for the first time, 1 hr for the second time, and 0.5 hr for the third time, wherein the water used for each extraction is 6 times of the weight of the medicinal materials, mixing extractive solutions, adding the concentrated medicinal liquid of step 1), and concentrating to obtain soft extract;
3) adding a proper amount of sucrose and dextrin into the thick paste (the weight ratio of the sucrose to the dextrin is 3: 1) stirring to form a holding mass, kneading to obtain loose soft material, sieving with 14 mesh sieve, extruding, granulating, drying, grading, and packaging.
Specification: 10 g/bag (equivalent to 8g of Chinese medicinal materials).
The characteristics are as follows: the solution is clear, fragrant, sweet and slightly bitter.
The usage and dosage are as follows: the preparation is administered about 7 days before menstruation until menstruation is finished, 10g each time, 3 times per day, and is dissolved in boiling water and placed for warm administration.
The functional indications are as follows: to soothe the liver, regulate qi, warm yang and alleviate pain. Can be used for treating secondary dysmenorrhea, dysmenorrhea due to cold accumulation, qi stagnation and blood stasis, and lumbago and skelalgia due to cold waist and abdomen and cold hands and feet.
Example 2
100g of white peony root, 50g of Chinese thorowax root, 50g of Chinese angelica, 50g of cornu cervi degelatinatum, 30g of ephedra herb, 30g of baked ginger, 30g of immature bitter orange and 20g of liquorice
The preparation method comprises the following steps: 1) extracting radix Paeoniae alba, bupleuri radix, and fructus Aurantii Immaturus with 50% ethanol under reflux for 3 times, each for 0.5 hr, mixing extractive solutions, and concentrating until there is no ethanol smell;
2) decocting radix Angelicae sinensis, Glycyrrhrizae radix, cornu Cervi Degelatinatum, herba Ephedrae, and rhizoma Zingiberis Preparata in water for 2 times, each for 3 hr, mixing extractive solutions, adding the concentrated medicinal liquid of step 1), and concentrating to obtain soft extract;
3) adding sucrose and dextrin into the soft extract, and making into granule by conventional method.
Example 3
160g of white peony root, 90g of Chinese thorowax root, 90g of Chinese angelica, 40g of cornu cervi degelatinatum, 40g of ephedra herb, 40g of baked ginger, 30g of immature bitter orange and 50g of liquorice
The preparation method comprises the following steps: 1) extracting radix Paeoniae alba, bupleuri radix, and fructus Aurantii Immaturus with 80% ethanol under reflux for 1 time for 2 hr, collecting extractive solution, and concentrating until no ethanol smell exists;
2) decocting radix Angelicae sinensis, Glycyrrhrizae radix, cornu Cervi Degelatinatum, herba Ephedrae, and rhizoma Zingiberis Preparata in water for 0.5 hr for 4 times, mixing extractive solutions, adding the concentrated medicinal liquid of step 1), and concentrating to obtain soft extract;
3) adding sucrose and dextrin into the soft extract, and making into granule by conventional method.
EXAMPLE 4 evaluation of clinical efficacy
1. General data
Selecting 120 outpatients who have been visited by the department of traditional Chinese medicine outpatient service in the monarch department in flood mountain area of Wuhan city in 2017, 6 months to 2019, randomly dividing the outpatients into two groups, wherein the two groups comprise 60 experimental groups, 60 control groups, 22-39 years old of experimental groups and 27.6 +/-3.2 years old of average age; the control group was 20-36 years old, the mean age was 25.1 + -3.7 years old, and the patients in both groups were comparable (P > 0.05).
2. Inclusion criteria
(1) The menstrual period and the week before and after menstruation have periodic abdominal pain and distention, with spasm and radiating pain, accompanied by pale complexion, nausea, emesis, aversion to cold, and collapse due to severe symptoms.
(2) Has history of onset of gynecological diseases such as pelvic inflammatory disease, endometriosis, adenomyosis, polyp of endometrium, uterine malformation, intrauterine adhesion, hysteromyoma, cervical cancer, abortion, etc.
(3) Scanty menstruation with unsmooth menstruation, anorexia, dizziness, wiry and thready pulse, pale tongue.
(4) The gynecological examination has no positive signs, and no serious organic diseases such as cardiovascular diseases, liver diseases, kidney diseases, etc.
3. Treatment regimens
The test group started taking the granules of the present invention (example 1) 7 days before menstruation, 10g each time, 3 times a day, and was taken with boiled water until the end of menstruation; the control group began to take Danggui and Shao powder (9 g of angelica, 48g of peony, 12g of tuckahoe, 12g of atractylodes, 24g of alisma orientale and 10g of ligusticum wallichii) 7 days before menstruation, 8g each time, 3 times a day, and the powder is taken with boiled water. Three menstrual cycles were administered consecutively.
4. Criteria for efficacy assessment
(1) And (3) healing: the abdominal pain symptom disappears completely in the menstrual cycle, and the menstrual flow is normal.
(2) The effect is shown: the abdominal pain symptom in the menstrual cycle is obviously improved, and other medicines are not needed to be taken, so that the patient can work and study normally.
(3) The method has the following advantages: the abdominal pain symptom in the menstrual cycle is slightly improved, other medicines are not needed, and the patient cannot work and learn normally and needs to lie in bed for rest.
(4) And (4) invalidation: there was no relief of abdominal pain symptoms during the menstrual cycle.
5. Test results
The curative effects of the patients in three menstrual cycles are respectively counted, the average value is taken, and the test results are shown in table 1.
TABLE 1 comparison of efficacy over three menstrual cycles of drug administration
Recovery method | Show effect | Is effective | Invalidation | Total effective rate (%) | |
Test group (60) | 7 | 28 | 21 | 4 | 93.3 |
Control group (60) | 4 | 17 | 28 | 11 | 81.7 |
Stopping taking the medicine after three continuous menstrual cycles, revisiting all patients after the fourth menstrual cycle, and counting the curative effect of the patients in the fourth menstrual cycle, wherein 11 patients in the test group lose contact, and 8 patients in the control group lose contact. The therapeutic effect after drug withdrawal is shown in Table 2.
TABLE 2 comparison of efficacy in the first menstrual cycle after drug withdrawal
Recovery method | Show effect | Is effective | Invalidation | Total effective rate (%) | |
Test group (49) | 5 | 13 | 17 | 14 | 71.4 |
Control group (52) | 2 | 9 | 10 | 31 | 40.4 |
From the results, the effective rate of the test group on the secondary dysmenorrhea reaches 93.3 percent, which is higher than 77.3 percent of that of the control group, and the significant difference (P <0.05) exists between the two groups, and the invention can still maintain 71.4 percent of effective rate after the last withdrawal until the next menstrual cycle, while the effective rate of the control group is only 40.4 percent, which has the significant difference (P <0.01) between the two groups, thus the invention has better long-term curative effect.
During taking the medicine, 7 patients in the test group have vomit symptoms, which are related to the reaction of the disease, are not treated, and can relieve the dysmenorrheal automatically after the dysmenorrheal disappears, and other local or systemic adverse reactions do not exist, so the traditional Chinese medicine has higher safety.
Claims (5)
1. The traditional Chinese medicine for treating secondary dysmenorrhea is characterized by being prepared from the following raw materials in parts by weight: 80-180 parts of white peony root, 30-90 parts of radix bupleuri, 30-90 parts of angelica, 30-90 parts of cornu cervi degelatinatum, 5-50 parts of ephedra, 5-50 parts of baked ginger, 30-90 parts of immature bitter orange and 20-60 parts of liquorice.
2. The traditional Chinese medicine for treating secondary dysmenorrhea according to claim 1, wherein the raw materials comprise, by weight: 100 portions of white peony root, 50 to 70 portions of bupleurum, 50 to 70 portions of angelica, 50 to 70 portions of deglued antler powder, 10 to 30 portions of ephedra, 10 to 30 portions of baked ginger, 50 to 70 portions of immature bitter orange and 30 to 50 portions of liquorice.
3. The traditional Chinese medicine for treating secondary dysmenorrhea according to claim 1, wherein the raw materials comprise, by weight: 120 parts of white peony root, 60 parts of radix bupleuri, 60 parts of angelica, 60 parts of cornu cervi degelatinatum, 20 parts of ephedra, 20 parts of baked ginger, 60 parts of immature bitter orange and 40 parts of liquorice.
4. A method for preparing the traditional Chinese medicine of any one of claims 1 to 3, characterized by comprising the steps of:
1) extracting radix Paeoniae alba, bupleuri radix, and fructus Aurantii Immaturus with 50-80% ethanol under reflux for 0.5-2 hr for 1-3 times, mixing extractive solutions, and concentrating until no alcohol smell exists;
2) decocting radix Angelicae sinensis, Glycyrrhrizae radix, cornu Cervi Degelatinatum, herba Ephedrae, and rhizoma Zingiberis Preparata in water for 0.5-3 hr for 2-5 times, mixing extractive solutions, adding the concentrated medicinal liquid of step 1), and concentrating to obtain soft extract;
3) adding adjuvants into the soft extract, and making into clinical preparation.
5. The method for preparing the traditional Chinese medicine according to claim 4, which is characterized in that: the medicament is an oral preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010286633.9A CN111298092B (en) | 2020-04-13 | 2020-04-13 | Traditional Chinese medicine for treating secondary dysmenorrhea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010286633.9A CN111298092B (en) | 2020-04-13 | 2020-04-13 | Traditional Chinese medicine for treating secondary dysmenorrhea |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111298092A CN111298092A (en) | 2020-06-19 |
CN111298092B true CN111298092B (en) | 2021-12-07 |
Family
ID=71154082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010286633.9A Active CN111298092B (en) | 2020-04-13 | 2020-04-13 | Traditional Chinese medicine for treating secondary dysmenorrhea |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111298092B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104873927A (en) * | 2015-05-12 | 2015-09-02 | 杭州美誉医药有限公司 | Traditional Chinese medicine preparation for treating irregular menstruation, as well as preparation method and application thereof |
CN110624087A (en) * | 2019-09-03 | 2019-12-31 | 长春中医药大学附属消化病医院有限公司 | Traditional Chinese medicine composition for soothing liver-qi stagnation and preparation and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100515481C (en) * | 2007-01-08 | 2009-07-22 | 山东泰坤中医药有限公司 | Traditional Chinese medicine for treating menorrhalgia |
CN103566320A (en) * | 2012-07-25 | 2014-02-12 | 天津太平洋制药有限公司 | Preparation method of Xiaoyao pill |
-
2020
- 2020-04-13 CN CN202010286633.9A patent/CN111298092B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104873927A (en) * | 2015-05-12 | 2015-09-02 | 杭州美誉医药有限公司 | Traditional Chinese medicine preparation for treating irregular menstruation, as well as preparation method and application thereof |
CN110624087A (en) * | 2019-09-03 | 2019-12-31 | 长春中医药大学附属消化病医院有限公司 | Traditional Chinese medicine composition for soothing liver-qi stagnation and preparation and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN111298092A (en) | 2020-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526634B (en) | Traditional Chinese medicine preparation for curing hyperplasia of mammary glands | |
US20060141071A1 (en) | Compositions and methods for treating gynecological disorders | |
CN103933353A (en) | Medicament for treating rheumatism and gout | |
CN102228603B (en) | Chinese medicine for treating retention of urine | |
CN103585378A (en) | A Chinese medicinal composition for treating female infertility, and its preparation method | |
CN101653590B (en) | Medicine for treating habitual abortion and preparation method thereof | |
CN102512564A (en) | Traditional Chinese medicine for treating dysmenorrhea | |
CN101011553A (en) | Chinese traditional medicine preparation for treating female barrenness | |
CN102526342B (en) | Traditional Chinese medicine preparation for treating chronic cervicitis | |
CN111298092B (en) | Traditional Chinese medicine for treating secondary dysmenorrhea | |
CN102343019B (en) | Chinese medicinal composition for treating amenorrhea and preparation method of preparation thereof | |
CN103301353A (en) | Pharmaceutical composition for treating atrophic vaginitis | |
CN105663408A (en) | Decoction medicine for treating abnormal menstruation and insufficient menstrual blood volume as well as preparation method thereof | |
CN105012379A (en) | Traditional Chinese medicine composition for treating salpingemphraxis sterility | |
CN114984168B (en) | Traditional Chinese medicine composition, peach red dredging mixture and preparation method and application thereof | |
CN103356959B (en) | Pharmaceutical composition for treating hyperplasia of mammary glands | |
CN107898974B (en) | Traditional Chinese medicine for treating dysmenorrhea of women | |
CN105963639A (en) | Traditional Chinese medicine composition for treating fallopian tube disease | |
CN117323403A (en) | Traditional Chinese medicine decoction for treating dysmenorrhea | |
CN105194577A (en) | Medicament for treating hyperplasia of mammary glands | |
CN105031552A (en) | Traditional Chinese medicine composition for treating gynecological tumors | |
CN114886986A (en) | A Chinese medicinal composition for treating menoxenia, amenorrhea and infertility | |
CN118178584A (en) | Traditional Chinese medicine composition for tonifying kidney, promoting blood circulation and nourishing fetus | |
CN114886946A (en) | Pharmaceutical composition and self-heating traditional Chinese medicine warm waist belt | |
CN113244345A (en) | Chinese medicinal compound preparation containing menstruation regulating seeds and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220919 Address after: A84-1, phase II, biological park, 858 Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430000 Patentee after: WUHAN YIYUANTANG BIOTECHNOLOGY Co.,Ltd. Address before: 430000 West Zone 1, block B, building 3, No. 465, Luoshi South Road, Hongshan District, Wuhan City, Hubei Province Patentee before: Wuhan Hongshan Yiyuan Tang Chinese Medicine Clinic Co.,Ltd. |
|
TR01 | Transfer of patent right |